Researchers identify potential target for developing obesity and diabetes treatment

August 9, 2018, CU Anschutz Medical Campus

A newly published study by researchers from the University of Colorado School of Medicine has identified a potential therapeutic target for treating obesity and diabetes.

The scientists studied the biological function of an epigenetic modifier known as histone deacetylase 11 (HDAC11), and determined that deleting it in mice stimulates the formation of brown adipose tissue. The absence of HDAC11 also triggered beiging of white adipose tissue. These changes are important because stores energy, while produces heat, thus expending energy. These findings reveal a regulatory node that could lead to the development of a pharmaceutical-based therapy for obesity and metabolic disease based on increasing energy expenditure.

The details of the study are published in the August 9 edition of JCI Insight, a journal published by the American Society for Clinical Investigation.

The first author of the study is Rushita A. Bagchi, Ph.D., a postdoctoral fellow in the laboratory of Timothy A. McKinsey, Ph.D., associate professor of medicine in the Division of Cardiology, who is the corresponding author of the article. Both are part of the Consortium for Fibrosis Research & Translation, a program funded by the School of Medicine to improve understanding of fibrotic diseases across various organ systems.

"The findings uncovered a druggable transcriptional pathway for regulation of energy expenditure, and thus suggest novel approaches for combating the global pandemics of obesity and diabetes based on HDAC11 inhibition," said McKinsey.

Obesity is an increasingly common health problem, with more than one-third of the U.S. population considered obese. Obesity and associated chronic diseases, such as type 2 diabetes, are projected to affect more than a half billion adults worldwide by 2040. Mice lacking HDAC11 were protected from obesity, insulin resistance and other effects of high-fat feeding. The findings suggest a previously unrecognized role for HDAC11, and an associated protein known as BRD2, in the control of adipose .

"Through our investigation we found that inhibiting HDAC11 increases , which highlights its potential as a target in and metabolic disease therapeutic strategies," said McKinsey. "We now need to test the role of HDAC11 in large animal models of and in human cell systems as we attempt to translate these exciting findings to the clinic."

Seventeen authors were listed on the article, "HDAC11 suppresses the thermogenic program of via BRD2." Nine of the authors are members of the CU School of Medicine. The research was supported with funding from the National Institutes of Health, the American Heart Association, and the Canadian Institutes of Health Research.

Explore further: Researchers report protein kinase as the switch controlling obesity and diabetes

More information: Rushita A. Bagchi et al, HDAC11 suppresses the thermogenic program of adipose tissue via BRD2, JCI Insight (2018). DOI: 10.1172/jci.insight.120159

Related Stories

Researchers report protein kinase as the switch controlling obesity and diabetes

July 18, 2018
One of the research lines targeting the worldwide obesity epidemic is the manipulation of brown adipose tissue, a 'good' type of fat that burns lipids to maintain an appropriate body temperature. Researchers at the Centro ...

Mechanism that converts white fat to brown identified

January 8, 2018
An international team of researchers led from Karolinska Institutet have, in experiments on mice, pinpointed a mechanism for the conversion of energy-storing white fat into energy-expending brown fat. The study is published ...

New findings on mechanisms for body temperature regulation by fat tissue

October 5, 2017
New discoveries about the mechanism responsible for heat generation in the body related to fat tissue oppose classical views in the field and could lead to new ways to fight metabolic disorders associated with obesity, according ...

Technology to drive advances in obesity-related diseases

December 11, 2017
For the first time, researchers led by Frank Lau, MD, Assistant Professor of Clinical Surgery at LSU Health New Orleans, have successfully kept white fat tissue alive outside of the body for up to eight weeks. This breakthrough ...

T-cells lacking HDAC11 enzyme perform more effectively in destroying cancer cells

July 17, 2017
Researchers at the George Washington University (GW) Cancer Center have discovered a new role for the enzyme, histone deacetylase 11 (HDAC11), in the regulation of T-cell function.

Recommended for you

Targeting a hunger hormone to treat obesity

October 22, 2018
About 64 per cent of Canadian adults are overweight or obese, according to Health Canada. That's a problem, because obesity promotes the emergence of chronic diseases such as type 2 diabetes, heart disease and some cancers.

Scientists in Sweden may have figured out one way acne bacteria defies treatment

October 22, 2018
Researchers in Sweden have discovered how acne-causing bacteria feed off their human hosts. The study, which was performed at KTH Royal Institute of Technology, could make it possible to find effective ways to treat severe ...

Gene plays critical role in noise-induced deafness

October 19, 2018
In experiments using mice, a team of UC San Francisco researchers has discovered a gene that plays an essential role in noise-induced deafness. Remarkably, by administering an experimental chemical—identified in a separate ...

Scientists grow functioning human neural networks in 3-D from stem cells

October 18, 2018
A team of Tufts University-led researchers has developed three-dimensional (3-D) human tissue culture models for the central nervous system that mimic structural and functional features of the brain and demonstrate neural ...

Functional engineered oesophagus could pave way for clinical trials 

October 18, 2018
The world's first functional oesophagus engineered from stem cells has been grown and successfully transplanted into mice, as part of a pioneering new study led by UCL.

New findings cast light on lymphatic system, key player in human health

October 16, 2018
Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.